Delivery Order SPE2DB24D1021-SPE2DB25FEZVD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count units) valued at $2,707.41. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,391.13 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count unit). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $22,397.23 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a ceiling value of $9,610.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,456.46 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $4,065.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count units) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a standard pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) with a ceiling value of $23,485.90. The contract, which is firm fixed price and non-set-aside, was awarded without special set-aside designations through competitive procurement and carries an ultimate completion date of August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,792.54 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) under a firm fixed-price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,623.35 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Contrave is an FDA-approved weight management medication...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZVDDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count packages). The contract, valued at $2,533.30, represents a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical support vehicle for federal medical procurement. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of federal contracts with the DLA Medical Supply Chain demonstrates its capability to fulfill diverse medical procurement requirements through competitive procurement, including specialty medications, vaccines, medical devices, and generic pharmaceuticals across multiple therapeutic domains. This delivery order for an obesity management medication aligns with the company's established role in supplying specialized pharmaceutical products to the Defense Health Agency and other government healthcare systems through its flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/18/25 |